11248 Federal Register / Vol. 70, No.
44 / Tuesday, March 8, 2005 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Indian Health Service
Health Professions Preparatory, Health
Professions Pregraduate and Indian
Health Professions Scholarship
Programs; Correction
ACTION: Notice; correction.
SUMMARY: The Indian Health Service
published a document in the Federal
Register on January 19, 2005. The
document contained one error.
FOR FURTHER INFORMATION CONTACT: Mr.
Jess Brien, Chief, Scholarship Branch,
Indian Health Service, 801 Thompson
Avenue, Suite 120, Rockville, Maryland
20852; telephone 301–443–6197. (This
is not a toll-free number.)
Correction
In the Federal Register of January 19,
2005, in FR Doc. 05–1030, on page 3046,
in the second column, correct the
Application Review Date to read April
18–April 22, 2005.
Dated: February 28, 2005.
Robert G. McSwain,
Deputy Director, Indian Health Service.
[FR Doc. 05–4479 Filed 3–7–05; 8:45 am]
BILLING CODE 4160–16–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Initial Review Group, Subcommittee
E—Cancer Epidemiology, Prevention &
Control.
Date: April 6–8, 2005.
Time: 7 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
VerDate jul<14>2003 19:54 Mar 07, 2005 Jkt 205001
Place: Holiday Inn Select Bethesda, 8120
Wisconsin Ave., Bethesda, MD 20814.
Contact Person: Mary C. Fletcher, PhD,
Scientific Review Administrator, Research
Programs Review Branch, Division of
Extramural Activities, National Cancer
Institute, National Institutes of Health, 6116
Executive Boulevard, Rm 8115, Bethesda,
MD 20892, (301) 496–7413.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS.)
Dated: March 1, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–4498 Filed 3–7–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel Sepsis and CAP:
Partnerships for Diagnostics Development.
Date: March 21–22, 2005.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Stefani T. Rudnick, PhD,
Scientific Review Administrator, Scientific
PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 E:\FR\FM\08MRN1.SGM
Review Program, Division of Extramural
Activities, National Institutes of Health/
NIAID, 6700B Rockledge Drive, MSC 7616,
Bethesda, MD 20892–7616, 301–496–2550,
srudnick@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel Hepatitis C Cooeprative
Research Centers.
Date: March 23–25, 2005.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Georgetown, 2101
Wisconsin Avenue, NW., Washington, DC
20007.
Contact Person: Gerald L. McLaughlin,
PhD, Scientific Review Administrator,
Scientific Review Program, Division of
Extramural Activities, National Institutes of
Health/NIAID, 6700B Rockledge Drive, MSC
7616, Bethesda, MD 20892–7616, 301–435–
2766, gm145a@nih.gov.
Name of Committee: National Institutes of
Allergy and Infectious Diseases Special
Emphasis Panel Novel HIV Therapeutics:
Integrated Preclinical/Clinical Program
(IPCP).
Date: March 23–25, 2005.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Silver Spring, 8777
Georgia Avenue, Silver Spring, MD 20910.
Contact Person: Tracy A. Shahan, PhD,
Scientific Review Adminsitrator, Scientific
Review Program, Divison of Extramural
Activities, National Institutes of Health/
NIAID, 6700B Rockledge Drive, MSC 7616,
301–496–2606, tshahan@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel Disorders of Therapeutic
Immunosuppression.
Date: March 23, 2005.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge 6700, 6700B Rockledge Drive,
3147, Bethesda, MD 20817, (Telephone
Conference Call).
Contact Person: Duane Price, PhD,
Scientific Review Administrator, NIAID,
DEA, Scientific Review Program, Room 2217,
6700B, Rockledge Drive, MSC 7616,
Bethesda, MD 20892–7616, (301) 496–2550;
dprice@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Emphasis
Panel ‘‘Animal Models for the Prevention
and Treatment of Hepatitis B and Hepatitis
C.’’
Date: March 24, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Holiday Inn Chevy Chase, 5520
Wisconsin Avenue, Chevy Chase, MD 20815.
Contact Person: Lucy A. Ward, DVM,
Scientific Review Administrator, Scientific
Review Program, Division of Extramual
Activities, National Institutes of Health/
NIAID, 6700B Rockledge Drive, Room 3117,
Bethesda, MD 20892–7616, (301) 496–2550;
lw275a@nih.gov.
08MRN1
 Federal Register / Vol. 70, No. 44 / Tuesday, March 8, 2005 / Notices
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel IPCP.
Date: March 31, 2005.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Double Tree Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Tracy A. Shahan, PhD,
Scientific Review Administrator, Scientific
Review Program, Division of Extramual
Activities, National Institutes of Health/
NIAID, 6700B Rockledge Drive, MSC 7616,
Bethesda, MD 20892–7616, (301) 496–2606;
tshahan@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS.)
Dated: March 1, 2005.
Anna P. Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–4487 Filed 3–7–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel Trauma and Burn Research Center
Program.
Date: March 29, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Select Bethesda, 8120
Wisconsin Ave., Bethesda, MD 20814.
Contact Person: Brian R. Pike PhD,
Scientific Review Administrator, Office of
Scientific Review, National Institute of
General Medical Sciences, National Institutes
of Health, 45 Center Drive, Room 3AN18,
Bethesda, MD 20892, (301) 594–3907,
pikbr@mail.nih.gov.
VerDate jul<14>2003 19:54 Mar 07, 2005 Jkt 205001
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS.)
Dated: March 1, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–4489 Filed 3–7–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee, Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel Exploratory Center Grants for hESC
Research.
Date: March 29–30, 2005.
Time: 9 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Rebecca H. Johnson, PhD,
Scientific Review Administrator, Office of
Scientific Review, National Institute of
General Medical Sciences, National Institutes
of Health, Natcher Building, Room 3AN18C,
Bethesda, MD 20892, 301–594–2771,
johnsonrh@nigms.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS.)
PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 E:\FR\FM\08MRN1.SGM
11249
Dated: March 1, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–4490 Filed 3–7–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Microbiology,
Infectious Diseases and AIDS Initial Review
Group Acquired Immunodeficiency
Syndrome Research Review Committee,
AIDS Research Review Committee.
Date: March 23–24, 2005.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, Bethesda, MD 20814.
Contact Person: Roberta Binder, PhD,
Scientific Review Administrator, Scientific
Review Program, Division of Extramural
Activities, NIAID/NIH/DHHS, Room 3130,
6700B Rockledge Drive, MSC 7616, Bethesda,
MD 20892–7616, (301) 496–7966,
rb169n@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS.)
Dated: March 1, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–4491 Filed 3–7–05; 8:45 am]
BILLING CODE 4140–01–M
08MRN1